(Q44606457)

4 December 2017

title

A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats (English)

1 reference

4 December 2017

main subject

pulmonary hypertension

1 reference

Takefumi Itoh

1

1 reference

4 December 2017

Noritoshi Nagaya

2

1 reference

4 December 2017

Takafumi Fujii

3

1 reference

4 December 2017

Takashi Iwase

4

1 reference

4 December 2017

Norifumi Nakanishi

5

1 reference

4 December 2017

Kaoru Hamada

6

1 reference

4 December 2017

Kenji Kangawa

7

1 reference

4 December 2017

Hiroshi Kimura

8

1 reference

4 December 2017

language of work or name

English

0 references

publication date

2 October 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

169

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

34-38

1 reference

Primary pulmonary hypertension. A national prospective study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Sildenafil modulates hemodynamics and pulmonary gas exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Beraprost therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Interaction of sildenafil with cAMP-mediated vasodilation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200303-346OC

10.1164/RCCM.200303-346OC

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference